Dogwood Therapeutics, Inc.
DWTX
$1.84
$0.010.55%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.50M | 6.10M | 9.86M | 10.34M | 9.72M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.60M | 27.97M | 31.70M | 18.20M | 15.34M |
| Operating Income | -28.60M | -27.97M | -31.70M | -18.20M | -15.34M |
| Income Before Tax | -28.29M | -34.04M | -38.02M | -24.55M | -21.79M |
| Income Tax Expenses | 31.70K | 221.00K | 188.70K | 190.10K | 190.00K |
| Earnings from Continuing Operations | -28.32 | -34.26 | -38.20 | -24.74 | -21.98 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.32M | -34.26M | -38.20M | -24.74M | -21.98M |
| EBIT | -28.60M | -27.97M | -31.70M | -18.20M | -15.34M |
| EBITDA | -28.58M | -27.93M | -31.67M | -15.86M | -11.95M |
| EPS Basic | -10.60 | -18.03 | -24.06 | -17.91 | -17.07 |
| Normalized Basic EPS | -6.63 | -8.53 | -12.05 | -8.21 | -7.68 |
| EPS Diluted | -10.60 | -18.03 | -24.06 | -17.91 | -17.07 |
| Normalized Diluted EPS | -6.63 | -8.53 | -12.05 | -8.21 | -7.68 |
| Average Basic Shares Outstanding | 51.90M | 19.79M | 6.58M | 5.77M | 4.78M |
| Average Diluted Shares Outstanding | 51.90M | 19.79M | 6.58M | 5.77M | 4.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |